42019-57-8 Usage
Physical appearance
White crystalline powder The compound's solid form appears as a white, crystalline substance.
Classification
Nonsteroidal anti-inflammatory drug (NSAID) It is a type of medication used to reduce inflammation and relieve pain without the use of steroids.
Mechanism of action
Inhibits production of pain-causing chemicals The drug works by reducing the levels of certain chemicals in the body that are responsible for causing pain and inflammation.
Common uses
Treatment of arthritis, menstrual cramps, and mild to moderate pain This medication is often used to alleviate various types of pain and inflammation, including those associated with arthritis and menstrual cramps.
Availability
Over-the-counter medication The chemical can be found in over-the-counter drugs, making it easily accessible for individuals to purchase and use as needed.
Medical guidance
Use as directed by a healthcare professional It is crucial to follow the instructions provided by a medical professional when taking this medication to ensure proper dosage and avoid potential side effects.
Potential side effects and interactions
Be aware of possible risks with other medications Users should be cautious about the potential side effects of the drug and any interactions it may have with other medications they are taking.
Check Digit Verification of cas no
The CAS Registry Mumber 42019-57-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,0,1 and 9 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 42019-57:
(7*4)+(6*2)+(5*0)+(4*1)+(3*9)+(2*5)+(1*7)=88
88 % 10 = 8
So 42019-57-8 is a valid CAS Registry Number.
42019-57-8Relevant articles and documents
Degradation Studies under Neutral and Basic Conditions on Ciprofibrate, an Orally Active Hypolipidemic Agent Containing a (4-Alkoxyaryl)-1,1-dichlorocyclopropane Unit
Dulayymi, Juma'a R. Al,Baird, Mark S.,Byard, Stephen J.,Carr, Glynis,Ellames, George J.,et al.
, p. 43 - 48 (2007/10/02)
The major product of degradation of ciprofibrate (1), 2-(4-(2,2-dichlorocyclopropyl)phenoxy>-2-methylpropanoic acid, in aqueous sodium hydroxide under reflux is 2--2-methylpropanoic acid (11).A further product, 2-(4-ethynylphenoxy)-2-methylpropanoic acid (12) is derived from 11 under the reaction conditions.A third degradant is identified as 2--2-methylpropanoic acid (13).Under similar conditions, but at pH 7, the products of degradation were found to be2--2-methylpropanoic acid (9) and (Z)-2--2-methylpropanoic acid (10).Treatment of 10 with aqueous sodium hydroxide under reflux afforded a mixture of products in which 11 and 12 predominated, whereas similar treatment of 9 led to compound 13 among other products.A labelling study indicates that the acid 21 derived from base treatment of 17 is labelled only at C-2 of the propanoic acid side chain; the same labelling pattern is observed in the acid 21 derived by base treatment of the labelled allylic alcohol 18.Mechanisms are suggested which may explain these observations.
